Condition: Migraine · Sponsor: H. Lundbeck A/S
The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 1 to 4 other available medications to prevent their migraines, but these medications have not helped them.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Accel Research Sites Network - Neurology and Neurodiagnostic of Alabama | Hoover, Alabama, United States | — |
| Profound Research - Neurology Center of Southern California | Carlsbad, California, United States | — |
| Neurology Center of North Orange County | Fullerton, California, United States | — |
| CenExel CNS | Los Alamitos, California, United States | — |
| ASCLEPES Research Centers | Sherman Oaks, California, United States | — |
| Ki Health Partners LLC DBA New England Institute for Clinical Research | Stamford, Connecticut, United States | — |
| K2 Medical Research - Winter Garden | Clermont, Florida, United States | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville, Florida, United States | — |
| K2 Medical Research, LLC - Maitland | Maitland, Florida, United States | — |
| Aqualane Clinical Research | Naples, Florida, United States | — |
| K2 Medical Research Tampa LLC | Tampa, Florida, United States | — |
| Premiere Research Institute Palm Beach | West Palm Beach, Florida, United States | — |
+ 108 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.